Updates are available Correction dated 2023-01-30
Click to view Correction: https://doi.org/10.1038/s41467-023-36226-4
-
Authors
Luqman-Fatah, Ahmad https://orcid.org/0000-0001-9220-0912
Watanabe, Yuzo
Uno, Kazuko
Ishikawa, Fuyuki
Moran, John V.
Miyoshi, Tomoichiro https://orcid.org/0000-0002-5319-7877
-
Funding
Funding for this research was provided by:
Japan Student Services Organization
MEXT | Japan Society for the Promotion of Science (JP19H05655)
U.S. Department of Health & Human Services | National Institutes of Health (GM060518)
Takeda Science Foundation
Japan Foundation for Applied Enzymology
Sumitomo Foundation
Astellas Foundation for Research on Metabolic Disorders
- License Information
-
More Information
Article History
Received: 19 March 2022
Accepted: 23 December 2022
First Online: 13 January 2023
Change Date: 30 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-36226-4
Competing interests
: J.V.M. is an inventor on patent US6150160, is a paid consultant for Gilead Sciences, serves on the scientific advisory board to Tessera Therapeutics Inc. (where he is paid as a consultant and has equity options), has licensed reagents to Merck Pharmaceutical, and recently served on the American Society of Human Genetics Board of Directors. The other authors declare no competing interests.
